American Express vs Amgen: Founders, CEOs and History
American Express was founded in 1850 by Henry Wells, William Fargo, John Warren Butterfield and is led by Stephen Squeri. Amgen was founded in 1980 by George B. Rathmann, William K. Bowes Jr. and is led by Robert A. Bradway.
Company facts
American Express
- Founded
- 1850
- Headquarters
- New York, New York
- Current CEO
- Stephen Squeri
- Employees
- 76,800
Amgen
- Founded
- 1980
- Headquarters
- Thousand Oaks, California
- Current CEO
- Robert A. Bradway
- Employees
- 31,500
Founders
American Express
Henry Wells
The founding of American Express is a fascinating story of intense 19th-century corporate rivalry culminating in a monopolistic merger.
William Fargo
William Fargo co-founded American Express in 1850 alongside Henry Wells and John Butterfield, bringing operational discipline and route management expertise to the merger of competing express businesses.
John Warren Butterfield
John Warren Butterfield was one of the three founders of American Express in 1850 and served as a director, bringing the organizational resources, political connections and financial backing that made the merger viable.
Amgen
George B. Rathmann
Amgen, originally incorporated as Applied Molecular Genetics, was founded in 1980 not by a single scientist, but by a calculated syndicate of venture capitalists and academics trying to commercialize the brand-new science of recombinant DNA.
William K. Bowes Jr.
William K. Bowes Jr. Was the venture capital strategist whose vision catalyzed Amgen's formation.
CEOs and their tenures
American Express
- Howard L. Clark Sr.1960–1977
President and Chief Executive Officer
Howard Clark became chief executive in 1960 and ran American Express until 1977. He inherited a charge card business that was losing money two years after launch and pushed it to profitability by repositioning it as a premium product, raising the merchant disc…
Source - James D. Robinson III1977–1993
Chairman and Chief Executive Officer
James Robinson III presided over American Express during a period of both genuine growth and serious strategic overreach.
Source - Harvey Golub1993–2001
Chairman and Chief Executive Officer
Harvey Golub inherited a company left unfocused and financially weaker by James Robinson III's financial conglomerate strategy.
Source - Kenneth Chenault2001–2018
Chairman and Chief Executive Officer
Kenneth Chenault led American Express for 17 years through two severe shocks: the September 11 attacks in 2001, which hit its lower Manhattan operations and its travel-dependent business weeks after he became chief executive, and the 2008 financial crisis, dur…
Source - Stephen J. Squeri2018–present
Chairman and Chief Executive Officer
Stephen Squeri took over from Kenneth Chenault in February 2018 and has run the most financially productive period in the company's history, with FY2025 total revenues net of interest expense of $72.2 billion and net income of $10.8 billion, both records.
Source
Amgen
- George B. Rathmann1980–1988
Chief Executive Officer
George Rathmann, a physical chemist who had run research and development at Abbott Laboratories, was named Amgen's first chief executive in 1980 and worked from a small trailer so that laboratory space could go to scientists.
Source - Gordon M. Binder1988–2000
Chief Executive Officer
Gordon Binder joined Amgen as chief financial officer in 1982 and led its June 1983 initial public offering.
Source - Kevin W. Sharer2000–2012
Chief Executive Officer
Kevin Sharer joined Amgen in 1992 as president and chief operating officer and became chairman and chief executive in 2000.
Source - Robert A. Bradway2012–present
Chairman and Chief Executive Officer
Robert Bradway became chief executive on May 23, 2012, succeeding Kevin Sharer as the fourth CEO in Amgen's history, and added the chairmanship at the start of 2013.
Source
Timeline: American Express and Amgen side by side
1850American Express
American Express founded in Buffalo, New York
Henry Wells, William Fargo and John Butterfield merged three competing express businesses on March 18, 1850 to form the American Express Company, an unincorporated joint-stock association capitalized at 150,000 dollars.
1882American Express
Money order launched
American Express introduced its own money order, competing directly with the postal money order the United States Post Office had offered since 1864.
1891American Express
Traveler's cheque invented
Marcellus Berry created the American Express Traveler's Cheque after president J.C. Fargo struggled to cash letters of credit on a European trip in 1890.
1917American Express
Federal control of the express industry
Federal control of the railroads began in December 1917, and in 1918 the domestic express operations of American Express and its rivals were consolidated into the American Railway Express Company.
1958American Express
First American Express charge card
American Express issued its first charge card on October 1, 1958, printed on paper with a 6 dollar annual fee, after signing up more than 250,000 card members before launch.
1966American Express
Gold Card introduced
American Express launched the Gold Card in 1966 for higher-spending executives and frequent travelers, the first tier above the standard card and the start of the graded premium lineup that later added the Platinum Card and the Centurion Card.
1980Amgen
Applied Molecular Genetics is incorporated
Applied Molecular Genetics (AMGen) was incorporated on April 8, 1980 in Thousand Oaks, California, as the idea of venture capitalist William K. Bowes Jr. and a group of scientific collaborators.
1983Amgen
Nasdaq listing and the erythropoietin clone
Amgen completed its initial public offering on June 17, 1983, raising nearly US$40 million under chief financial officer Gordon Binder, and formally shortened its name to Amgen.
1984American Express
Platinum Card launched during the financial supermarket build-out
American Express introduced The Platinum Card by invitation in 1984 with a 250 dollar annual fee, creating the ultra-premium card category.
1984Amgen
Kirin-Amgen joint venture formed
Amgen and Kirin Brewery Company of Japan formed Kirin-Amgen in 1984 as a joint venture for the worldwide commercialization of erythropoietin.
1985Amgen
G-CSF cloned, leading to Neupogen
While Fu-Kuen Lin's team worked on erythropoietin, researcher Larry Souza and his group cloned and expressed human granulocyte colony-stimulating factor in 1985.
1989Amgen
FDA approves Epogen
The FDA approved Epogen (epoetin alfa) on June 1, 1989 for anemia in patients with chronic kidney failure on dialysis. It was the first commercial recombinant human erythropoietin. Epogen's U.S.
1991Amgen
Neupogen approved, giving Amgen a second franchise
The FDA approved Neupogen (filgrastim) in February 1991. By stimulating white blood cell production it reduced the risk of infection in cancer patients with chemotherapy-induced neutropenia.
1991Amgen
Amgen wins the erythropoietin patent fight
On March 6, 1991 the U.S. Court of Appeals for the Federal Circuit upheld the Kirin-Amgen erythropoietin patent and ruled against Genetics Institute in Amgen v. Chugai Pharmaceutical and Genetics Institute.
1993American Express
Harvey Golub refocuses the company
Harvey Golub became chief executive in 1993 and unwound the conglomerate: the Shearson brokerage went to Primerica's Smith Barney and The Boston Company to Mellon Bank in 1993, and Lehman Brothers was spun off in 1994.
1999American Express
Centurion Card launched
American Express created the Centurion Card in 1999, an invitation-only metal card that became the top tier of its lineup. The company has never published its fee schedule, and the product functions mainly as a positioning device for the cards below it.
2001American Express
Kenneth Chenault becomes chief executive
Kenneth Chenault became chief executive in January 2001, weeks before the September 11 attacks damaged the company's lower Manhattan operations and cut travel spending sharply.
2001Amgen
FDA approves Aranesp, the longer-acting EPO
Aranesp (darbepoetin alfa), an erythropoietin analogue with modified glycosylation and a longer half-life, was approved in 2001. Less frequent dosing than Epogen improved convenience and gave Amgen a newer, higher-priced product to migrate patients toward.
2002Amgen
US$16 billion Immunex acquisition brings Enbrel in-house
Amgen completed its acquisition of Immunex Corporation on July 16, 2002, the largest biotechnology deal to that point at about US$16 billion in stock and cash.
2008American Express
Conversion to a bank holding company
On November 10, 2008 the Federal Reserve Board approved applications by American Express Company and American Express Travel Related Services to become bank holding companies, on conversion of American Express Centurion Bank from an industrial loan company int…
2010Amgen
Prolia and XGEVA create the bone health franchise
The FDA approved Prolia (denosumab) for postmenopausal osteoporosis in June 2010 and XGEVA, the same molecule at a higher dose, for prevention of skeletal-related events in cancer patients in November 2010.
2016American Express
Costco co-brand ends
Costco moved its United States co-branded card to Citigroup and Visa on June 20, 2016, ending a 16-year exclusive relationship after the two sides failed to agree terms, and stopped accepting American Express cards in its warehouses.
2018American Express
Stephen Squeri becomes chairman and chief executive
Stephen Squeri succeeded Kenneth Chenault in February 2018 after more than three decades inside the company, including spells as chief information officer and group president of Global Corporate Services.
2019Amgen
US$13.4 billion purchase of Otezla from Celgene
Amgen agreed in August 2019 to buy worldwide rights to Otezla (apremilast) from Celgene for US$13.4 billion in cash, or about US$11.2 billion net of the present value of US$2.2 billion of anticipated future cash tax benefits, and closed on November 21, 2019.
2020American Express
Pandemic hits travel and entertainment spending
COVID-19 restrictions cut the travel and entertainment spending American Express depends on, and total revenues net of interest expense fell from 43.6 billion dollars in 2019 to 36.1 billion dollars in 2020, with net income down to 3.1 billion dollars.
2020Amgen
Amgen joins the Dow Jones Industrial Average
Amgen replaced Pfizer in the Dow Jones Industrial Average on August 31, 2020, becoming one of the thirty components in the index. Inclusion recognized the scale Amgen had reached and added passive demand from Dow-tracking funds.
2023Amgen
US$27.8 billion Horizon Therapeutics acquisition closes
Amgen completed the acquisition of Horizon Therapeutics plc on October 6, 2023 for US$116.50 per share in cash, an equity value of about US$27.8 billion, after settling FTC litigation with a behavioral consent decree.
2024American Express
Tock acquisition widens the dining platform
American Express agreed in June 2024 to buy Tock, a reservation, table and event management platform, from Squarespace for 400 million dollars in cash, pairing it with Resy, which it had bought in 2019.
2024Amgen
Imdelltra becomes the first T-cell engager for small cell lung cancer
The FDA granted accelerated approval to tarlatamab, sold as Imdelltra, on May 16, 2024 for extensive stage small cell lung cancer that has progressed on or after platinum-based chemotherapy.
2025American Express
Platinum refresh and record FY2025 results
American Express unveiled refreshed United States Consumer and Business Platinum Cards on September 18, 2025, raising the annual fee from 695 dollars to 895 dollars and adding statement credits it values at over 3,500 dollars a year.
2025Amgen
VESALIUS-CV extends the Repatha case to primary prevention
In November 2025 Amgen reported Phase 3 VESALIUS-CV results in more than 12,000 patients with atherosclerosis or diabetes but no prior heart attack or stroke.
2026Amgen
Medicare price setting reaches Enbrel and Otezla
Enbrel's negotiated Medicare price under the Inflation Reduction Act took effect on January 1, 2026, after it was named in the first round of ten drugs selected for negotiation.
Acquisitions
American Express
- Center2025Undisclosed
- Tock2024$400M
- Kabbage2020Undisclosed
- Resy2019Undisclosed
- Loyalty Partner2011$660M
- Thomas Cook corporate travel and United States travel offices1994$375M
Amgen
- Horizon Therapeutics plc2023$27.8B
- ChemoCentryx, Inc.2022$3.7B
- Five Prime Therapeutics2021$1.9B
- Celgene Otezla Business2019$13.4B
- Onyx Pharmaceuticals, Inc.2013$10.4B
- DeCODE Genetics2012$415M
Questions about American Express vs Amgen
Who is the CEO of American Express Company and Amgen Inc.?
American Express Company is led by Stephen Squeri and Amgen Inc. is led by Robert A. Bradway. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was American Express Company founded vs Amgen Inc.?
American Express Company was founded in 1850 — 130 years before Amgen Inc., which was founded in 1980. American Express Company's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Amgen Inc..
How many employees does American Express Company have compared to Amgen Inc.?
American Express Company employs approximately 76,800 people, while Amgen Inc. employs approximately 31,500. American Express Company has the larger workforce at 76,800 employees, compared to Amgen Inc.'s 31,500. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are American Express Company and Amgen Inc. headquartered?
Both American Express Company and Amgen Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded American Express Company and Amgen Inc.?
American Express Company was founded by Henry Wells, William Fargo, John Warren Butterfield. Amgen Inc. was founded by George B. Rathmann, William K. Bowes Jr..
Which company has a longer operating history — American Express Company or Amgen Inc.?
American Express Company has been operating for approximately 176 years, making it the more established of the two companies. Amgen Inc. has been in operation for around 46 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the American Express vs Amgen overview